Determinants of Compliance With Glaucoma Therapy

This study is currently recruiting participants.

Verified by University of Alabama at Birmingham, August 2006

First Received: August 9, 2006 No Changes Posted

Sponsors and Collaborators:	University of Alabama at Birmingham Alcon Research
Information provided by:	University of Alabama at Birmingham
ClinicalTrials.gov Identifier:	NCT00362622

Purpose

To determine the association between medical, demographic, socioeconomic, and therapeutic differences on compliance with topical glaucoma therapy using the Travalert device.

Condition
Open Angle Glaucoma

Study Type:	Observational
Study Design:	Screening, Longitudinal, Defined Population, Retrospective/Prospective Study
Official Title:	Determinants of Compliance With Glaucoma Therapy

Resource links provided by NLM:

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma

U.S. FDA Resources

Further study details as provided by University of Alabama at Birmingham:

Estimated Enrollment:	50
Study Start Date:	October 2005
Estimated Study Completion Date:	December 2006

Detailed Description:

To determine the association between medical, demographic, socioeconomic, and therapeutic differences on compliance with topical glaucoma therapy using the Travalert device. All participants will have open angle glaucoma.

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Must have open angle glaucoma Over age 19

Exclusion Criteria:

less than 19

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00362622

Contacts

Contact: Roberta A Hill, RN	205-325-8325	bahill@uab.edu
Contact: Dina V Avery, MA	205-325-8614	dvavery@uab.edu

Locations

United States, Alabama
University of Alabama at Birmingham	Recruiting
Birmingham, Alabama, United States, 35294
Contact: Dina V Avery, MA 205-325-8614 dvavery@uab.edu
Contact: Roberta A Hill, RN 205-325-8325 bahill@uab.edu
Principal Investigator: Jason Swanner, MD
Sub-Investigator: Christopher A Girkin, MD
Sub-Investigator: Matthew Sapp, MD

Sponsors and Collaborators

University of Alabama at Birmingham

Alcon Research

Investigators

Principal Investigator:	Christopher A Girkin, MD	University of Alabama at Birmingham
Principal Investigator:	Jason Swanner, MD	University of Alabama at Birmingham
Principal Investigator:	Matthew Sapp, MD	University of Alabama at Birmingham

More Information

No publications provided

Study ID Numbers:	X050826003
Study First Received:	August 9, 2006
Last Updated:	August 9, 2006
ClinicalTrials.gov Identifier:	NCT00362622 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Alabama at Birmingham:

Travalert
open angle glaucoma

Study placed in the following topic categories:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Hypertension
Ocular Hypertension

Additional relevant MeSH terms:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Ocular Hypertension

ClinicalTrials.gov processed this record on September 02, 2009